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Abstract Optical coherence tomography (OCT) is a novel
intravascular imaging modality using near-infrared light. By
OCT it is possible to obtain high-resolution cross-sectional
images of the vascular wall structure and assess the acute
and long-term effects of percutaneous coronary interven-
tion. For the time being OCT has been mainly used in
research providing new insights into the pathophysiology
of the atheromatic plaque and of the vascular response to
stenting, however, it seems that there is potential for clinical
application of OCT in various fields, such as pre-interventional
evaluation of coronary arteries, procedural guidance in coro-
nary interventions, and follow-up assessment of vascular heal-
ing after stent implantation. This review will focus on the
potential and advantages of OCT in the clinical practice of a
catheterization laboratory.
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Introduction
Since the introduction of percutaneous coronary intervention
(PCI), coronary angiography has been the tool for assessing the
need for revascularization, as well as for assessing the results of
the interventions. The advent of intravascular ultrasound
(IVUS) has opened a new chapter in PCI guidance, enabling
the transition from assessment of the lumen to the direct
assessment of plaque and vessel morphology and the evalua-
tion of the vessel wall response to stenting. Utilizing this
approach, IVUS studies have provided useful insights into
the pathogenesis and prevention of stent failure [1–3] as well
as the dynamic nature of atherosclerosis and the impact of
medical therapy [4–6]. Despite, however, the enormous contri-
bution of IVUS, it is limited by low axial resolution (100–
150 μm) and poor capability to discriminate different plaque
components that precludes assessment of specific plaque and
stent characteristics. Technological advances have led to the
development of new intravascular imaging methods. We will
discuss the potential and advantages of optical coherence to-
mography (OCT) in the clinical practice of a catheterization
laboratory. Table 1 summarizes some potential clinical appli-
cations of OCT.
Basic Principles of OCT Imaging
OCT is an intravascular imaging method capable of proving
cross-sectional images of the vascular wall with a high axial
resolution (5–15μm) and a lateral resolution of approximately
25 μm. This high resolution, however, comes at a cost of
reduced penetration depth caused by the rapid attenuation of
light waves in the tissue, and of the need to temporarily
displace blood during imaging, because of the high scattering
of light caused by erythrocytes. OCT in contrast to IVUS is
based on emission of near-infrared light rather than acoustic
waves for imaging. These infrared light waves reflect off the
vascular wall and are then received and processed by the OCT
imaging system. As the wavelength of light waves is far
greater than those of the intravascular ultrasound, OCTcannot
directly interpret the signal, but uses instead a technique called
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low-coherence interferometry in order to process the reflected
signal. By this technique, an interferogram is created that can
be analyzed by the imaging system in order to interpret the
reflection as temporal delay or as tissue length (A-line) [7••].
Time-Domain and Fourrier-Domain OCT Systems
There are two processing methods that are being used for
intravascular OCT imaging: Time Domain OCT (TD-OCT),
and the recently introduced Fourier Domain OCT (FD-OCT),
which is also known as second generation OCT, Frequency
DomainOCT, or Optical FrequencyDomain Imaging (OFDI).
FD-OCT systems can record A-lines at a very high speed,
while improving noise-signal ratios resulting in greater pene-
tration depth, without loss of vital detail or resolution. In this
way, imaging acquisition time and contrast used is reduced,
while longer pullbacks are acquired [8].
Intravascular FD-OCT Systems and Image Acquisition
Technique
Currently available FD-OCT systems are utilizing a short
rapid-exchange monorail catheter for mounting of the opti-
cal probe. The optical signal is transmitted by a single-mode
fiber, automatically mounted on the catheter, the focus of
which is approximately 1 mm outside the catheter. In order
to scan the vessel lengthwise, the catheter imaging tip is
pulled back while rotating, inside a transparent sheath,
allowing for retrieval of consecutive cross-sectional images
for a length of 50–70 mm from the coronary artery. Both
rotary and pullback motion are driven proximally by a
motor outside the patient. For image acquisition, the FD-
OCT catheter is initially advanced with the aid of a conven-
tional guidewire distally to the desired segment, while the
catheter position is indicated by radio-opaque markers. In
order to create a blood-free environment during the acqui-
sition, contrast warmed to 37 °C is injected, either manually,
or by a power injector at a rate of 3–4 mL/sec. Pullback of
the optical fiber is being performed simultaneously with the
contrast injection.
Safety and Efficacy of OCT Imaging
The first experimental and human studies of TD-OCT
have shown the safety and feasibility of OCT imaging
using a proximal occlusion balloon for blood clearance
[9]. An alternative technique eliminating the need for
proximal occlusion has also demonstrated a favorable
safety profile [10]. In the first systematic attempt from
a multicenter registry of 468 patients undergoing TD-
OCT imaging either with the occlusive or the non-
occlusive technique, to record the safety of optical co-
herence tomography, use of the non-occlusive technique
was associated with a reduction in the rate of transient
complications during image acquisition such as chest
pain and ECG changes [11••]. The introduction of FD-
OCT led to a significant improvement in the rate of
images of usable quality by simultaneously reducing
acquisition time and the rate of transient chest pain and
ECG changes [8]. Furthermore, use of a FD-OCT system
for guidance of intervention was associated with a favorable
safety profile [12].
Table 1 Potential clinical applications of optical coherence tomogra-
phy (OCT)
Setting Application
Lesion evaluation Assessment of culprit lesion in acute coronary
syndromes: evaluation for plaque rupture and/or
thrombus in patients without angiographically
evident culprit lesion
Evaluation of lesions with angiographic haziness:
differential diagnosis between thrombus,
dissection, heavy calcification
Determination about presence or absence of
plaque (e.g. in coronary spasm)
Pre-procedural
assessment
Luminal measurements for selection of balloon
and stent dimensions
Assessment of plaque morphology in order to
guide therapeutic strategy and device selection
(rotablation, cutting balloon, etc.)
Evaluation of the optimal location in the vessel for
implantation of a coronary stent
Use for tracking the exact guidewire position
(i.e. in chronic total occlusion or in bifurcation
stenting)
Use in bifurcation intervention (assessment of
carina, ostia of side-branches, stent cell
geometry)
Post-procedural
assessment
Assessment of stent expansion (detection of
under-expansion, residual stenosis, incomplete
stent apposition)
Assessment of vascular injury: detection of edge
dissections, tissue protrusion, intra-stent
thrombus
Assessment of intervention by adjunctive
devices: measurement of luminal enlargement
after cutting balloon angioplasty, assessment of
the reduction of calcification after rotablation
Assessment of adjunctive therapies in acute
coronary syndromes: evaluation of residual
thrombus burden after thrombectomy or
selective administration of IIb/IIIa antagonists
Follow-up stent
assessment
Mid-term and long-term assessment of stent safety
and efficacy: evaluation of stent restenosis
(quantitative and qualitative), stent thrombosis,
and stent coverage as a surrogate for vessel
healing
Monitoring of the bioresorption and the healing
response after implantation of bioresorbable
scaffolds
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Plaque Characterization and Quantitative Measurements
OCT is an imaging method that can accurately measure
lumen and stent dimensions with high agreement with his-
tological specimens and characterize tissue with high sensi-
tivity and specificity. By OCT, it is possible to visualize all
three arterial layers in a normal coronary artery, in accor-
dance with pathological specimens [13]. OCT allows differ-
entiation of fibrous, fibrocalcific, and lipid-rich tissue by
visual assessment of the standard intensity image [14].
Briefly, fibrous plaque is seen as a high-intensity, low-
attenuation area, lipid as a low-intensity, high-attenuation
area with diffuse borders, while calcium as low-intensity,
low-attenuation area with sharp borders (Fig. 1) [14]. OCT
can also detect thrombus with very high sensitivity and
specificity, and allows for distinction between red (erythro-
cyte-rich) and white (platelet-rich) thrombus [15].
Several studies have validated the ability of OCT to
perform quantitative measurements of the lumen and stent
area [7••, 16, 17]. Meanwhile, in vivo studies have con-
firmed that there is high correlation between OCT and IVUS
measurements of vessel and stent dimensions, as well as that
there is very low intra-observer and inter-observer variabil-
ity in the assessment of stent and vessel area [18]. Measure-
ments acquired by FD-OCT systems seem to be equally
accurate and reproducible [19]. The recent introduction of
algorithms allowing for the automated quantitative assess-
ment of lumen dimensions enables the acceleration of the
analysis process [20–22]. Various algorithms and software
packages have been suggested for this approach [20], while
the ability of these automatic quantification programs to
detect with high correlation with histology and manual
interpretation the luminal and stent borders allows for the
rapid online assessment of the degree of stenosis, reference
site diameter, and degree of neointimal hyperplasia [21, 22].
Role of OCT in Pre-interventional Decision Making
Intermediate Lesions
Accurate measurements of lumen area by OCT can be used
for the evaluation of intermediate lesions. It has been shown
in IVUS studies, that angiography often underestimates the
Fig. 1 Representative optical
coherence tomography (OCT)
cross-sectional images of a
normal vessel with high-power
view demonstrating the three
layers of the vascular wall: b
fibrous plaque; c lipid-rich
plaque; d fibrocalcific plaque
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plaque burden and the severity of stenosis [23]. Thus, eval-
uation of intermediate lesions has been a focus of invasive
imaging. Functional assessment of intermediate lesions
using fractional flow reserve (FFR) in patients with stable
disease has been shown in large-scale studies to be linked
with improved outcomes as it overcomes limitations of
angiography [24]. Despite the existence of IVUS studies
assessing quantitative indices of stenosis as a marker of
the functional significance of a lesion, it remains questionable
whether functional measurements can be replaced by anatom-
ic measurements by IVUS or OCT. Taking into account,
however, that various parameters, such as lesion length, lesion
location, and plaque burden are factors also affecting the
functional significance of a lesion, it is doubtful that the
physiological significance of a lesion can be accurately
assessed by measurement of minimal lumen area alone [25].
Moreover, a recent evaluation of IVUS and OCT to assess the
physiological significance of a stenosis revealed that despite
OCT measurements of minimal lumen area having greater
diagnostic potential than IVUS for the assessment of the phys-
iological significance of intermediate stenosis, anatomic lesion
assessment by either modality correlates poorly to physiologic
measurements performed by FFR [26]. Consequently, the cur-
rent golden standard to assess hemodynamic relevance in a
patient with stable angina is functional measurement by FFR
(what to treat?), while OCT is helpful in guiding the procedure
(how to treat?) or identification of the culprit and thrombosed
lesion in acute coronary syndromes with intermediate lesions.
Angiographic Haziness
A field were OCT could substantially improve preproce-
dural assessment is in the evaluation of hazy lesions
(Fig. 2). It is known that angiographic haziness could be
due to a variety of morphological features such as thrombus,
heavy calcification, extreme tortuosity, and intimal dissec-
tion. There have been several reports of utilizing OCT for
the assessment of the nature of haziness, that have ranged
from extreme vessel tortuosity to vessel dissection and
recanalised thrombus [27–29]. Furthermore, the use of
IVUS would be less helpful in such cases, as its diagnostic
accuracy for complicated plaque and thrombus detection is
limited [30].
Evaluation of Coronary Spasm
Optical coherence tomography can also aid decision making
in cases of acute coronary syndromes in patients where coro-
nary spasm appears to be the culprit. Use of OCT in this subset
of patients can exclude the presence of culprit atheromatic
plaques and/or thrombus. The association of plaque morphol-
ogy with coronary spasm has been evaluated by OCT, show-
ing that the main underlying morphology is transient intima-
media thickening [31]. Multiple lumen irregularities observed
during the episode consisting of intimal bumps and intimal
gathering disappear after intracoronary nitrate administration,
giving place to normal vessel morphology [31].
Assessment of Plaque Morphology
One of the advantages of OCT is that it can assist in the
preprocedural evaluation of coronary lesions by providing
information about the morphology of the lesions. A small
study recently evaluated the complementary use of FD-OCT
with FFR in order to assess angiographically ambiguous
lesions. In this study, FFR was used in order to provide
information about the functional significance of these
lesions, while FD-OCT was used in order to assess the
presence of unstable plaques and guide decision making in
cases of ACS and FFR values >0.80 [32]. Moreover, the
underlying plaque type has been associated with the out-
come of the intervention. The presence of lipid-rich plaques
by OCT has been associated with greater incidence of non-
reflow and greater rise in biomarkers of cardiac necrosis in
Fig. 2 Evaluation by OCT of a
patient with acute coronary
syndrome and haziness in the
coronary angiogram. OCT
revealed the presence of
thrombus
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several studies [33]. Additionally, patients with unstable
angina compared to stable patients had greater rates of acute
malapposition and tissue protrusion post PCI, while they
had higher rates of malapposition and incomplete coverage
at 9-month follow-up, implying an association between
complicated plaque morphology—which was more com-
mon in the unstable angina group—with impaired vessel
healing after stenting [34].
It remains to be proven whether qualitative assessment of
non-culprit lesions can guide decision for treatment and im-
prove patient-related outcomes. A recent intravascular ultra-
sound study suggested an association of the presence of a non-
culprit lesion with small lumen area, large plaque burden and
plaquemorphology, as identified by radiofrequency ultrasound
analysis, with subsequent re-hospitalizations and events [6].
However, the prognostic value of intravascular ultrasound with
radiofrequency signal analysis for vulnerable plaque identifi-
cation and risk stratification still needs to be established.
Preprocedural Guidance
Selection of PCI Strategy
OCT can be used in order to guide decisions about treatment
before the procedure. As discussed above, OCT can provide
precise area measurements not only of the minimal lumen,
but of proximal and distal reference sites as well, and define
the lesion length. Therefore, preprocedural measurements
by OCT can aid in the proper selection of balloon and stent
dimensions. Selection of appropriate balloon size using
OCT measurements has been performed in a series of
patients undergoing cutting balloon angioplasty for the treat-
ment of in-stent restenosis [35]. Furthermore, OCT has also
been used for selection of treatment strategy on the basis of
lesion morphology. Given that OCT can quantify calcifica-
tions of the target site more accurately than IVUS [36], it
could better assess the need for targeted therapies (Fig. 3). In
a recent study, pre-interventional OCT assessment of plaque
morphology guided the selection of dedicated treatments
such as rotablation, thrombectomy, and cutting balloon in
one third of patients [37•]. In the same study, decision to
defer angioplasty was taken in 18 % of the patients using
criteria of IVUS guidance [38], for assessing the severity of
the lesion.
One of the advantages of OCT guidance is that it can help
precisely identify the optimal segment for stent deployment,
the so-called “landing zone” (Fig. 4). It has been shown that
multiple plaque morphologies may be present in the culprit
lesion of a patient with ACS [39]. Moreover, the longitudinal
analysis of culprit lesions of ACS has demonstrated that in the
majority of cases there is geographic mismatch of the minimal
lumen site with the rupture site [40•], indicating the presence
of necrotic core plaques in sites remote to the site of the
greatest stenosis. Although there is not definitive evidence
that stenting should also cover lipid-rich plaques located in
shoulder areas, it has been shown that presence of such areas
in the edge of the stent is associated with edge dissection, as is
the presence of fibrocalcific plaques [41]. Additionally, path-
ologic studies have shown the association of late stent throm-
bosis with the presence of struts penetrating areas of necrotic
core [42], while as mentioned earlier, possible stent-induced
disruption of such areas could lead to impaired vascular heal-
ing or raise in cardiac necrosis biomarkers [33, 34].
Co-registration of Invasive Imaging and Coronary
Angiography
While invasive imaging generally offers high spatial reso-
lution, it can be challenging to consolidate the information
Fig. 3 a Angiogram of the right coronary artery of a patient with
stable angina. b L-mode reconstruction of OCT images demonstrating
the longitudinal morphology of the lesion. c, d Representative OCT
cross-sections showing heavily superficially calcified plaque suggest-
ing the need for targeted therapy such as rotablation. Asterisks repre-
sent calcific depositions
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gained by invasive imaging technologies with the angio-
gram, and especially, to ensure correct spatial orientation.
This is true for all angiographically silent lesions, whereas
this phenomenon might be a consequence of vessel overlap,
foreshortening or the inability to visualize a complex three-
dimensional structure correctly in a two-dimensional image.
Often operators use side branches as observed in both im-
aging modalities as landmarks. This approach is not always
the optimal, as side branch ostia are not always clearly
visible by angiography and also the assumed calibre of a
particular side branch can be underestimated. Currently, a
number of technical solutions to this problem are being
developed, including the use of pulsed fluoroscopy to track
the imaging catheter in real time (Siemens Medical proto-
type, Erlangen, Germany) [43] or alternatively, approaches
for software enabled synchronization of three-dimensional
angiography with invasive imaging pullbacks are being
developed (Medis Medical Imaging Systems BV, Leiden,
The Netherlands) (Fig. 4) [44]. The ultimate goal is an
online co-registration of the invasive imaging modality with
the coronary angiogram, allowing the operator to scroll
through a synchronized dataset. Such information could
be useful for planning of the most appropriate interven-
tional strategy and for the longitudinal assessment of athero-
sclerotic lesions.
Guidance in Complex Procedures
OCT can also be a tool for guidance during complex
procedures. There have been reports of OCT guidance in
chronic total occlusions (CTOs) [45]. In such cases, OCT
can be used to identify the entry point of the occlusion
and to confirm that the guidewire is indeed in the true
vessel lumen and has not entered a false lumen. The
development of forward-looking OCT catheters will en-
able the guidance of a CTO crossing by continuous
visualization of the position of the guidewire relative to the
microchannels.
Fig. 4 Registration of 3D QCA and OCT using qAngioOCT (Medis
Medical Systems BV, Leiden, The Netherlands). a Fibrous cap at the
minimal lumen area (red marker). Images at the right indicate proximal
and distal landing zone. In the proximal landing zone there is a thin cap
fibroatheroma. b If a shorter stent is selected, the proximal landing
zone will be at a site with stable plaque. c, d Online three-dimensional
reconstructions of the segment generated by the software
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Bifurcation lesion stenting is another potential applica-
tion of OCT guidance. By 3-dimensional reconstruction of
OCT images it is possible to produce images that indicate
the relative position of the main vessel and the side-branch
and help select a suitable strategy [46]. Furthermore, three-
dimensional models of coronary arteries can help identify
the point of re-crossing of a guidewire in a side branch
through the cells of a stent implanted in the main vessel,
and evaluate possible presence of struts at the ostia of the
side branches following kissing balloon dilation [47]. The
development of online reconstructions that incorporate
three-dimensional angiography and optical coherence to-
mography images could improve real-time guidance in these
subsets of lesions [44, 48•].
Assessment of Acute Effects of PCI
Pathologic studies have indicated the association of implan-
tation characteristics with late events following stent im-
plantation [49]. Stent strut malapposition has been
associated with very late stent thrombosis in IVUS studies
[1]. Furthermore, postprocedural lesion assessment has
shown that stent expansion, tissue protrusion, and dissection
are associated with early stent thrombosis [2, 3], while
restenosis is also associated with inadequate stent expansion
[3]. Indeed, use of standardized criteria for stent expansion
using IVUS guidance and additional treatment based on
these criteria was associated with a low restenosis rate in
the bare metal stent era [38].
OCT can accurately assess the acute vessel wall response
to stent implantation. Due to the high resolution of OCT,
tissue prolapse, malapposition, intra-stent thrombus forma-
tion, and edge dissection can be detected more accurately
than with IVUS (Fig. 5), while stent and luminal measure-
ments by the two modalities are not significantly different
[7••, 9, 50]. In a study assessing the effects of stenting on
vessel wall morphology, it was shown that the presence of
dissections, either at the stent edge or inside the stent, and
tissue protrusion was observed in almost all the cases, while
in the majority of patients there was some degree of stent
malapposition [51•]. Thrombus presence inside the stent
was also common, both in stable and in ACS patients
[51•]. Furthermore, optical coherence tomography is partic-
ularly useful in the assessment of malapposition, due to its
superior resolution allowing the detection of small degrees
of malapposition not detectable by IVUS with low variabil-
ity between independent measurements. As OCT signal
does not penetrate the surface of stent struts, it is important
when calculating the distance of the stent strut from the
vessel wall, to subtract the thickness of the strut and poly-
mer from the total distance from strut surface to vessel wall.
Acute malapposition has been assessed in a variety of stud-
ies, and was found to be associated with plaque and stent
characteristics, clinical syndrome, and presence of overlap-
ping stents (Fig. 6) [34, 52].
Fig. 5 Assessment of acute effects of intervention. a Patient with edge
dissection after stent implantation at the bifurcation segment. b Intra-
stent dissection following stent implantation at the left circumflex
artery. c Tissue protrusion (9 to 10 o’clock) following stent implantation
at the middle left anterior descending artery. d Stent protrusion to the
diagonal branch following primary percutaneous intervention at the left
anterior descending artery without kissing balloon dilation
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The significance, however, and prognostic value of the
detection of small degrees of malapposition, tissue protru-
sion, or thrombus that are detectable only with the high-
resolution of OCT has not been precisely defined, as with
IVUS. Small follow-up studies have tried to assess the
impact of these findings with surrogate markers at follow-
up [34, 50, 53]. Acute malapposition was more pronounced
in implantation compared to follow-up in all of the studies
[34, 50, 53]. Conversely, there were cases of initially well-
apposed struts that were malapposed at follow-up, possibly
due to changes in vessel remodelling [53]. In one of the
studies, presence of malapposition was associated with im-
paired endothelialization and presence of thrombus on struts
[53]. Dissections and tissue protrusion, detectable by OCT,
tended to resolve at a 6-month follow-up period [50]. Nev-
ertheless, unless larger prospective studies investigate the
impact of OCT-detected markers of vessel injury and acute
malapposition by OCT on clinical outcome, their role in
decision making will remain uncertain.
Post-procedural OCT guidance has not been only used to
evaluate vascular injury following stent implantation, but
has also been used to assess the effects after PCI with other
adjunctive devices such as cutting or scoring balloon and
rotational atherectomy [54]. Furthermore, OCT can also be
used in ACS in order to assess the role of adjunctive ther-
apies in reducing thrombus burden (Fig. 7) [55, 56].
There is only a handful of studies that have assessed
the role of OCT guidance in PCI [12, 35, 37•]. Imola et
al. [12] used post-implantation OCT imaging in 74
patients in order to assess the need for further interven-
tion. In 24 patients, additional interventions were per-
formed based on OCT assessment (15 patients with
balloon metadilation and 9 patients with additional stent
implantation), while in 50 patients the result of the
Fig. 6 Correction of
malapposition at the proximal
LAD following stent
implantation. a Angiographic
result following the initial
intervention. b OCT
demonstrating malapposition at
the proximal LAD. c Post-dilation
was performed with a non-
compliant balloon. d Final
angiographic result. eOCTshows
correction of malapposition
(the distance of the strut surface
from the vessel wall is lower than
the thickness of the strut and
polymer, as provided by the
manufacturer)
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interventions was judged satisfactory, leading to an
event-free survival of 98 % at 6-month follow-up. Use
of OCT in assessing luminal dimensions after cutting
balloon angioplasty has led to the safe upsizing of lumi-
nal size in patients without coronary stent implantation
[35]. Viceconte et al. [37] report on the outcomes of an
OCT-guided strategy for procedural guidance, where in
207 cases, OCT suggested the need of a new stent
implantation in 29 and further optimization in 64. No
major complications were observed in this study, while
serial OCT examinations increased procedural time by a
mean of 15.4±8.2 min. Thus, it seems that OCT can be
safely used for procedural guidance, but the clinical
significance of such an approach remains to be assessed
in comparative studies.
Assessment of Long-Term Outcome After PCI
OCTcan be a valuable tool for follow-up stent assessment. The
association of the extent of stent endothelialization with stent
thrombosis in pathologic studies have introduced the need for
detailed assessment of stent coverage, as a surrogate marker for
stent safety. The superior resolution of OCT allows for near-
histology assessment of stent coverage, while the ability of
OCT to assess and quantify neointimal hyperplasia with greater
accordance with histology compared to IVUS, has clearly been
documented (Fig. 8) [57]. Furthermore, the high reproducibil-
ity for measurements of neointimal hyperplasia makes OCT a
reliable tool for objective evaluation of the degree of restenosis.
In view of these advantages, OCT has been used for the
assessment of the anti-restenotic efficacy of various devices.
Fig. 7 a Coronary angiography
of the right posterolateral
branch of a patient with
myocardial infarction. b OCT
reveals significant thrombus
burden (yellow arrow). c
Angiography after manual
thrombus aspiration. d OCT
shows reduction of the
thrombus burden, confirming
the effectiveness of thrombus
aspiration
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The assessment of neointimal coverage by OCT consti-
tutes the subject of various studies trying to provide insights
into subjects related to stent safety. Stent evaluation by OCT
can be used to provide detailed information for stent cover-
age reported to be associated with stent thrombosis in post-
mortem studies. It is important to mention that although
OCT can detect even minimal tissue coverage at an order
of 10 μm, which compares to analysis by optical microsco-
py, OCT detected coverage could correspond either to true
endothelialization or to coverage by fibrin deposits [58].
Therefore, OCT has only about 80 % sensitivity and 95 %
specificity for the detection of stent struts lacking endothe-
lial coverage [59]. Nevertheless, due to different optical
properties of these components, future developments with
characterization based on optical properties [59] may be
able to increase the sensitivity for detection of struts without
endothelial coverage.
Assessment of tissue coverage has been extensively in-
vestigated in the case of the sirolimus-eluting stent, where
there are reports from 3 months to 4 years post implantation
[60, 61]. All these reports suggest that a small percentage of
uncovered struts can be found even 4 years after implanta-
tion in sirolimus-eluting stents [61]. Sirolimus-eluting
stents, as well as paclitaxel-eluting stents, demonstrate im-
paired healing compared to bare-metal stents [62, 63]. This
does not seem to be the case for the zotarolimus-eluting
stent with permanent polymer that is probably the stent with
the highest extent of coverage, comparable to that of bare
metal stents [64]. Furthermore, comparative studies between
sirolimus-eluting and paclitaxel-eluting stents have demon-
strated that the latter are associated with an enhanced heal-
ing response [65]. A recent OCT substudy of a randomized
trial comparing a zotarolimus-stent with biocompatible
polymer and the everolimus-eluting stent has shown com-
parable rates of coverage between these two second-
generation stents [66]. Nonetheless, despite the presence of
profound differences in vessel healing between different
stents, these have not been shown yet to correspond to
differences in stent thrombosis, underlining the complexity
of mechanisms associated with this entity [67].
Pathologic evidence has shown that bare metal stents are
sometimes associated with development of neointimal tissue
Fig. 8 Various patterns of vessel response at the follow-up of stent
implantation. a Homogeneous tissue coverage without compromise of
the lumen. b Heterogeneous coverage with areas resembling lipid
plaques 3 years after implantation of a drug-eluting stent. c Stent
restenosis. d Presence of uncovered struts in another site of the stent
shown in panel B. e Stent malapposition at follow-up, with tissue cover-
age probably corresponding either to fibrin or endothelial coverage
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with characteristics similar to de novo atherosclerosis [68].
Furthermore, recent observations have shown that this entity
is also observed in drug-eluting stents at shorter follow-up
intervals [69]. The fact that OCT allows for qualitative
assessment of restenotic tissue can be used for elucidating
the mechanisms behind late stent failure. Various morpholog-
ical classifications of restenotic tissue have been proposed by
OCT [59, 70, 71], however histologic validation was only
available in the recent study by Nakano et al. [59], that
proposed the use of a classification similar to the classification
used for OCT assessment of de novo atheromatosis.
According to this study, the differences in the optical
properties of the various tissue components can be used
for tissue characterization.
Whether such morphological features are implicated in
the pathophysiology of very late stent thrombosis is a sub-
ject of investigation. Recent data from OCT studies suggest
the existence of two discrete mechanisms associated with
stent thrombosis: one involving impaired vessel healing
after stent implantation with malapposition and incomplete
strut coverage, and one associated with rupture of neoather-
osclerotic tissue [72]. Histological examination of thrombus
aspirates supports this theory by showing differences in the
composition of thrombotic debris between these two mech-
anisms [72, 73]. However, little is known so far about the
incidence and predictors of each mechanism, the “vulnera-
ble” neointimal morphological characteristics, and the dif-
ferences in clinical outcome in these cases. Future OCT
studies will provide new insights into the role of each
mechanism in the development of very late stent thrombosis
and will assess the clinical significance of evaluation of
these mechanisms.
OCT for the Assessment of New Stent Technologies
Due to its superior resolution and the ability to evaluate stent
healing and quantify neointimal hyperplasia, OCT is becom-
ing the standard for the assessment of new stent technologies.
A new biolimus-eluting stent underwent OCT evaluation in a
substudy of the LEADERS trial in order to assess the differ-
ences in healing response compared to a sirolimus-eluting
stent and was shown to be associated with more complete
coverage without increase in neointimal hyperplasia [74].
Moreover, various stents with improvements in release kinet-
ics, coating or matrix design have been evaluated with OCT in
order to assess if such improvements correspond to improved
healing response as well [75, 76]. Likewise, OCT has been
used in a number of studies to evaluate the healing response
after treatment with drug-eluting balloons in de novo or in
stent restenosis lesions [77].
One of the more fascinating aspects of OCT is the ability
to monitor the absorption rate in bioabsorbable stents. OCT
has been used for assessment of the biodegradation of the
magnesium stent in porcine coronary arteries, as it can
demonstrate the reduction in the width of stent struts that
is associated with biodegradation [78]. In the case of
the bioresorbable everolimus-eluting scaffold (Absorb™,
Abbott Vascular, Santa Clara, CA) there have been more
extensive animal and human studies [79–81]. Experi-
mental studies have shown that OCT can assess the
integration process of the scaffold in long-term observa-
tions [81]. In human studies, pilot trials have defined
the OCT appearance of various stages of the resorption
of the scaffold [79, 80], while OCT has been used for
assessment of the vascular healing process and evalua-
tion of differences in resorption and stent strut distribu-
tion between the first and the second generation of the
scaffold [82], being the best method for measurement of
stent length and luminal dimensions [83], as well as
assessment of healing in side branches [84].
Future Research Directions
Intravascular OCT is a powerful and easily applicable tool
for the assessment of the coronary artery. Today, OCT image
interpretation and analysis is based on a color-coded inten-
sity map. Algorithms enabling automated tissue character-
ization software will allow for a more objective assessment
of plaque morphology [85]. New technologies such as
polarization-sensitive OCT will enable the distinction of
the collagen content of the coronary plaques [86], while
the development of micro-OCT will help the better under-
standing of the pathophysiological mechanisms of acute
coronary syndromes [87].
Despite the numerous clinical uses of OCT, and a
wealth of case series and clinical observations illustrating
potential use in a clinical setting, no clear indications
have been established yet. Future studies, focusing either
on unselected population or on specific patient and lesion
subsets (i.e., acute coronary syndromes, calcified lesions,
bifurcations), will determine the role of OCT in proce-
dural guidance.
Furthermore, given that OCT can provide us with an
enormous amount of information about plaque morphology
and vessel healing following stent implantation, future re-
search will elucidate which are the critical components of
plaque and stent “vulnerability” on which we should focus.
Finally, natural history studies investigating the impact of
vessel morphology and acute procedural complications, as
detected by OCT, on future clinical events need to be imple-
mented. And if an association of such OCT findings with
clinical outcome is demonstrated, it remains to be seen if
treatment based on those findings can lead to an improve-
ment in outcomes.
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Conclusions
The introduction of OCT has not only provided new insights
in the pathophysiology of the plaque and of the vascular
response to stenting, but has also offered interventional cardi-
ology a new tool for procedural guidance. Currently, there are
no clear indications for OCT in a clinical setting; however,
there are numerous fields where useful decision-guiding in-
formation could be provided by OCT. These include pre-
interventional evaluation of coronary arteries, procedural
guidance in coronary interventions, as well as follow-up as-
sessment of vascular healing after stent implantation. The
development of three-dimensional models reconstructed from
OCT images could perhaps enhance the role of OCT in
procedural guidance [44], while automated tissue character-
ization software will allow for more objective assessment of
plaque morphology [85], strengthening the role of OCT as a
tool for implementation of natural history studies. Studies
aiming to show an association between OCT imaging and
improvement in patient-related outcomes will ultimately de-
fine the role of OCT in interventional cardiology.
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